title: Effect of naloxone on plasma adrenocorticotropin levels and beta-endorphin-like immunoreactivity in bilaterally adrenalectomized patients with Cushing's disease and in Addison's disease.
authors.forename: A
authors.initials: A
authors.lastname: Kasperlik-Załuska
authors.forename: W
authors.initials: W
authors.lastname: Jeske
authors.forename: B
authors.initials: B
authors.lastname: Migdalska
authors.forename: P
authors.initials: P
authors.lastname: Soszyński
authors.forename: T
authors.initials: T
authors.lastname: Wiśniewska-Woźniak
mesh_terms: D000224:Addison Disease / Q000097:blood*; D000315:Adrenalectomy; D000324:Adrenocorticotropic Hormone / Q000097:blood*; D000328:Adult; D003480:Cushing Syndrome / Q000097:blood* / Q000503:physiopathology; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D009270:Naloxone / Q000008:administration & dosage*; D011863:Radioimmunoassay; D001615:beta-Endorphin / Q000097:blood*
chemical_list: D009270:Naloxone; D001615:beta-Endorphin; D000324:Adrenocorticotropic Hormone